Asia Pacific Mesotherapy Market Forecast to 2030 - Regional Analysis by Product Type, Indication, and End Users

The Asia Pacific mesotherapy market was valued at US$ 106.91 million in 2022 and is expected to reach US$ 224.42 million by 2030; it is estimated to register a CAGR of 9.7% from 2022 to 2030.

Improvements in Comfort, Efficiency, and Outcomes with Technological Advancements Boost Asia Pacific Mesotherapy Market

Technological developments such as automated injection devices, nanotechnology, and no-needle mesotherapy have improved treatment outcomes, enhanced patient comfort, and increased efficiency in mesotherapy treatments. The introduction of these technologies has revolutionized the way mesotherapy products are delivered. For instance, automated injection devices use advanced technology to precisely manage the depth, pace, and volume of injections, ensuring that the drugs are accurately placed in the skin. Automated injection devices improve the uniformity and efficacy of mesotherapy treatments, along with lowering the risk of human errors, thereby improving the outcomes.

Similarly, nanotechnology has enabled the development of specific mesotherapy formulations that use nano-sized particles to improve active ingredient distribution to the skin. Liposomes, for instance, are lipid-based vesicles that can encapsulate medicinal substances and transport them to specific locations, thereby improving their absorption and bioavailability. These improved delivery technologies provide higher ingredient penetration, increased therapy efficacy, and sustained release of active compounds, resulting in longer-term results in patients.

No-needle mesotherapy treatments use ultrasonic technology. This type of mesotherapy is a safe method of delivering cosmeceutical and injectable compounds into the middle layer (mesodermis) of the skin. Natural serums are carried deep into the cellular level via small channels under the skin surface by utilizing a mild low-frequency current in conjunction with ultrasound. Natural elements such as antioxidants, vitamins, peptides, and hyaluronic acid help make the skin appear healthier, smoother, toned, and youthful. Thus, advancements in mesotherapy technology play a significant role in driving the growth of the mesotherapy market.

Asia Pacific Mesotherapy Market Overview

The Asia Pacific mesotherapy market is expected to grow at a high CAGR from 2022 to 2030. The market in China and Japan is expected to grow at a fast pace due to the increasing popularity of mesotherapy and growing medical tourism. In China, mesotherapy is gaining significant traction in various public and private hospitals. On the other hand, the market in India is expected to pick pace in the coming years with ongoing developments in healthcare and increasing people's willingness to spend on such procedures. Meanwhile, the mesotherapy market in South Korea is likely to flourish with the increasing cosmetic tourism. China holds the largest mesotherapy market in Asia Pacific.

The burgeoning aesthetic industry, high prevalence of skin diseases, growing awareness of cosmetic procedures to enhance aesthetic appeal, and increasing demand for minimally invasive procedures (for skin rejuvenation and enhancement) propel the market growth in this country. According to the Shanghai Municipal People's Government, ~70% of people in China suffer from skin problems, such as eczema and shingles. It is also reported that eczema, skin pruritus, and shingles are the top 3 skin diseases diagnosed in the elderly population. Eczema and Shingles can be treated through mesotherapy.

Asia Pacific Mesotherapy Market Segmentation

• The Asia Pacific mesotherapy market is categorized into product type, indication, end users, and country.
• Based on product type, the Asia Pacific mesotherapy market is segmented into mesotherapy solution kits, mesotherapy devices, mesotherapy fillers kits, mesotherapy chemical peels, and anti-ageing masks. The mesotherapy solution kits segment held the largest market share in 2022.
• In terms of indication, the Asia Pacific mesotherapy market is segmented into anti-ageing & wrinkle treatment, facial rejuvenation, fat loss, hair loss, stretch marks, and acne & scar treatment. The anti-ageing & wrinkle treatment devices segment held the largest share of Asia Pacific mesotherapy market in 2022.
• Based on end users, the Asia Pacific mesotherapy market is categorized into dermatology clinics, cosmetic clinics, hospitals, and others. The dermatology clinics segment held the largest share of Asia Pacific mesotherapy market in 2022.
• Based on country, the Asia Pacific mesotherapy market is categorized into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China dominated the Asia Pacific mesotherapy market share in 2022.
• Koru Pharma Co Ltd, Institute BCN Esthetics SL, Mesoskinline ApS, Colgate Palmolive Co, Toskani SL, Mesoestetic E-Commerce SL, Galderma SA, Derm Beauty International Sdn Bhd, Mesotech Srl, and Ostar Beauty Sci-Tech Co Ltd are some of the leading companies operating in the Asia Pacific mesotherapy market.

Market Highlights

• Based on product type, the Asia Pacific mesotherapy market is segmented into mesotherapy solution kits, mesotherapy devices, mesotherapy fillers kits, mesotherapy chemical peels, and anti-ageing masks. The mesotherapy solution kits segment held 48.4% market share in 2022, amassing US$ 51.75 million. It is projected to garner US$ 110.15 million by 2030 to register 9.9% CAGR during 2022-2030.
• In terms of indication, the Asia Pacific mesotherapy market is segmented into anti-ageing & wrinkle treatment, facial rejuvenation, fat loss, hair loss, stretch marks, and acne & scar treatment. The anti-ageing & wrinkle treatment devices segment held 35.6% share of Asia Pacific mesotherapy market in 2022, amassing US$ 38.01 million. It is anticipated to garner US$ 83.75 million by 2030 to expand at 10.4% CAGR during 2022-2030.
• The dermatology clinics segment held 47.4% share of Asia Pacific mesotherapy market in 2022, amassing US$ 50.63 million. It is predicted to garner US$ 108.83 million by 2030 to expand at 10.0% CAGR between 2022 and 2030.
• This analysis states that China captured 30.3% share of Asia Pacific mesotherapy market in 2022. It was assessed at US$ 32.39 million in 2022 and is likely to hit US$ 70.32 million by 2030, registering a CAGR of 10.2% during 2022-2030.

Reasons to Buy

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific mesotherapy market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific mesotherapy market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific mesotherapy market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.